Company AIT Therapeutics Inc Other OTC
Equities
US50027L1070
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
||
- USD | - |
|
Business Summary
Sales per Business
USD in Million | 2023 | Weight | 2024 | Weight | Delta |
---|---|---|---|---|---|
Beyond Air
100.0
%
| 0 | nan % | 1 | 100.0 % | - |
Sales per region
USD in Million | 2023 | Weight | 2024 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | nan % | 1 | 100.0 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Steven Lisi
CEO | Chief Executive Officer | 53 | 17-01-12 |
Douglas Larson
DFI | Director of Finance/CFO | 53 | 21-08-31 |
Amir Avniel
PSD | President | 50 | 17-01-12 |
Andrew Colin
CTO | Chief Tech/Sci/R&D Officer | - | 21-11-30 |
Chief Tech/Sci/R&D Officer | - | - | |
Jeff Myers
CTO | Chief Tech/Sci/R&D Officer | - | 23-03-26 |
Michael Gaul
COO | Chief Operating Officer | 70 | 20-04-30 |
Edward Barger
IRC | Investor Relations Contact | - | 22-09-30 |
Kori-Ann Taylor
SAM | Sales & Marketing | - | 21-05-19 |
Peter Senior
PRN | Corporate Officer/Principal | - | 21-05-02 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Ronald Bentsur
BRD | Director/Board Member | 58 | 15-07-31 |
William Forbes
BRD | Director/Board Member | 62 | 18-08-12 |
Erick Lucera
BRD | Director/Board Member | 57 | 17-08-09 |
Steven Lisi
CEO | Chief Executive Officer | 53 | 17-01-12 |
Amir Avniel
PSD | President | 50 | 17-01-12 |
Robert Carey
BRD | Director/Board Member | 65 | 19-02-12 |
Yoori Lee
BRD | Director/Board Member | 51 | 18-01-01 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 45,900,821 | 37,322,801 ( 81.31 %) | 0 | 81.31 % |
Company contact information
![address AIT Therapeutics Inc](https://cdn.zonebourse.com/static/address/27377775.png)
Sector
Sales per Business
1st Jan change | Capi. | |
---|---|---|
-6.24% | 180B | |
-6.08% | 99.21B | |
-5.98% | 66.25B | |
-9.35% | 44.74B | |
+8.34% | 43.82B | |
+10.35% | 41.96B | |
+11.88% | 28.98B | |
-8.38% | 23.5B | |
+16.18% | 24.07B |
- Stock Market
- Equities
- XAIR Stock
- Stock
- Company AIT Therapeutics Inc